Dr Ralph & Marian Falk Medical Research Tr
EIN 366975534Total Given 2020–2024
$38.1M
105 grants · $7.6M avg/year
based on 5 yrs of IRS 990-PF records on file
$1M+/yr
mid-tier
capacity
$177K
typical big bets · $148K–$205K
grant size
56%
supporter · 22/39 multi-year
repeat
$187.5M
Assets (2024)
39
Distinct Recipients
About
CASH
Focus Areas
Application Information
Accepts Unsolicited Proposals
Unknown
Contact Person
MS LAUREN MACDONALD
Phone
(888) 866-3275
Deadlines
PREFERENCE IS ACADEMIC RESEARCH INSTITUTIONS. ALL GRANTS ARE FOR RESEARCH OF DISEASES WITH
How to Apply
PROPOSAL WITH FULL WRITTEN NARRATIVE OF THE REQUEST; PLUS SUPPORTING INFORMATION. ROLLING ADMISSIONS
Restrictions
NO KNOWN CURE.
Financial Trends
Giving Over Time
Total Assets Over Time
View financial data as table
| Year | Total Giving | Total Assets | Revenue | Grants |
|---|---|---|---|---|
| 2020 | $7.0M | $170.2M | $10.1M | 1 |
| 2021 | $6.9M | $190.4M | $27.8M | 1 |
| 2022 | $8.4M | $167.9M | $7.8M | 20 |
| 2023 | $8.0M | $167.0M | $5.2M | 46 |
| 2024 | $7.8M | $187.5M | $8.2M | 37 |
Grant Size Distribution
Based on 105 grants on record
Minimum
$18K
25th Pctl
$148K
Median
$177K
Average
$363K
75th Pctl
$205K
Maximum
$7.0M
Geographic Distribution
Officers & Directors
BA
Bank of America N a
5+ yrs
Trustee
BA
Bank of America N a
5+ yrs
Trustee
BA
Bank of America N a
5+ yrs
Trustee
BA
Bank of America N a
5+ yrs
Trustee
BA
Bank of America N a
5+ yrs
Trustee
Grants Awarded (105 total)
| Purpose | ||||
|---|---|---|---|---|
| See Attached | See Attached, RI | $6,977,935 | UNRESTRICTED GENERAL | 2020 |
| See Attached | See Attached, RI | $6,905,713 | UNRESTRICTED GENERAL | 2021 |
| Medical College of Wisconsin | Milwaukee, WI | $1,179,871 | RESEARCH FOR CHRONIC PAIN; | 2022 |
| Childrens Hospital Medical Center | Cincinnati, OH | $1,130,000 | RESEARCH FOR PARKINSONS, | 2022 |
| Cleveland Clinic Foundation | Cleveland, OH | $1,070,000 | GLIOBLASTOMA TREATMENTS & | 2022 |
| Yale University School of Medicine | New Haven, CT | $1,070,000 | DEVELOPE CANCER VACCINES; | 2022 |
| Regents of University of Michigan | Pittsburgh, PA | $869,930 | DEVICE TO PREDICT | 2022 |
| Brown University of Providence | Providence, RI | $504,854 | ANTI-MALARIA DRUGS TARGETNG | 2023 |
| University of Cincinnati | Cleveland, OH | $497,018 | INHIBITORS TARGETING PEANUT | 2024 |
| Brown University of Providence | Providence, RI | $495,146 | ANTI-MALARIA DRUGS TARGETNG | 2024 |
| Stanford University | Menlo Park, CA | $460,000 | BIOMARKERS FOR IMMUNE | 2022 |
| Indiana University | Bloomington, IN | $445,923 | TARGETING PEANUT-SPECIFIC | 2023 |
| Michigan State University | East Lansing, MI | $400,000 | NOVEL RXR AGONIST FOR | 2022 |
| Medical College of Wisconsin | Milwaukee, WI | $377,004 | NEW DRUGS TO TREAT | 2024 |
| MEDICAL COLLEGE OF WISCONSIN sen neuron | Milwaukee, WI | $346,469 | DEVELOPMENT OF SENSORY | 2023 |
| Case Western Reserve University | Cleveland, OH | $343,159 | B CELL CANCER THERAPY USING | 2024 |
| Cleveland Clinic Foundation | Cleveland, OH | $336,255 | DEVELOPMENT OF NEW DRUG FOR | 2024 |
| Thomas Jefferson University | Philadelphia, PA | $333,333 | PROTACS FOR TARGETING BRCA | 2023 |
| Thomas Jefferson University | Philadelphia, PA | $333,333 | PROTACS FOR TARGETING BRCA | 2024 |
| Northwestern University | Evanstone, IL | $331,974 | T CELL THEARPY FOR | 2023 |
| Indiana University | Detroit, MI | $320,000 | TARGETING PEANUT-SPECIFIC | 2022 |
| Medical College of Wisconsin | Milwaukee, WI | $318,948 | DEVELOPMENT OF SENSORY | 2024 |
| Case Western Reserve University | Cleveland, OH | $301,032 | B CELL CANCER THERAPY USING | 2023 |
| Case Western Reserve University | Cleveland, OH | $260,000 | IMMUNOTHERAPY FOR B CELL | 2022 |
| Universityof Minnesota | Minneapolis, MN | $235,086 | THYROID HORMONE | 2024 |